Table 2.
Response rate to proton pump inhibitor (PPI) therapy assessed using gastrin 17 (G17), according to PPI dosing, in both patients with and without CAG.
| PPI Therapy Dosing | ||||
|---|---|---|---|---|
| N. 1015 |
Half 294 |
Full 709 |
High 12 |
|
|
Adequate response G17 >7, n.,
% |
354 (34.9) |
85 (28.9) |
261 (36.8) |
8 (66.7) |
|
Low response G17 1-7, n.,
% |
417 (41.1) |
139 (47.3) |
277 (39.1) |
1 (8.3) |
|
No response G17 < 1, n.,
% |
207 (20.4) |
65 (22.1) |
141 (19.9) |
1 (8.3) |
|
CAG, n.,
% |
37 (3.6) |
5 (1.7) |
30 (4.2) |
2 (16.7) |
CAG: chronic atrophic gastritis; G17: gastrin 17; PPI: proton pump inhibitors.